BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15488701)

  • 1. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.
    Akita S; Daian T; Ishihara H; Fujii T; Akino K
    J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activation of extracellular signal-regulated kinase in human dermal fibroblasts by human telomerase reverse transcriptase and transforming growth factor-beta1.
    Liu WR; Lu L; Rosenberg DS; Procaccini PS; Mustoe TA
    J Surg Res; 2007 Dec; 143(2):415-21. PubMed ID: 17662305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
    Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.
    Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H
    J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
    Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
    Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
    Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
    Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
    Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.
    Govindarajan B; Mizesko MC; Miller MS; Onda H; Nunnelley M; Casper K; Brat D; Cohen C; Arbiser JL
    Clin Cancer Res; 2003 Aug; 9(9):3469-75. PubMed ID: 12960139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
    Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1alpha) in tendon fibroblasts.
    Petersen W; Varoga D; Zantop T; Hassenpflug J; Mentlein R; Pufe T
    J Orthop Res; 2004 Jul; 22(4):847-53. PubMed ID: 15183444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye.
    Ash J; McLeod DS; Lutty GA
    Mol Vis; 2005 Apr; 11():298-308. PubMed ID: 15889014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.